These findings indicate that there is a quantifiable number of LCMV GP CD8 T cells required to cause diabetes and that a therapeutic approach directed to lowering or limiting; but not necessarily eliminating virus (self) specific CD8 T cells is likely to be successful in treating T1D. Here, CD8A is linked to diabetes mellitus.